Cargando…

Editorial: Pharmacotherapy of Anxiety Disorders: Promises and Pitfalls

Detalles Bibliográficos
Autores principales:	Garakani, Amir, Freire, Rafael C., Murrough, James W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8012478/ https://www.ncbi.nlm.nih.gov/pubmed/33815180 http://dx.doi.org/10.3389/fpsyt.2021.662963

Ejemplares similares

Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment Options
por: Garakani, Amir, et al.
Publicado: (2020)

Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment Options
por: Garakani, Amir, et al.
Publicado: (2021)

Editorial: Assessing and evaluating the impact of the COVID-19 pandemic on anxiety and stress: perspectives from North America
por: Salehi, Mona, et al.
Publicado: (2023)

Dissociation and Brain Rhythms: Pitfalls and Promises
por: Grent-'t-Jong, Tineke, et al.
Publicado: (2021)

A Feasibility Study of the Addition of STEPPS in Outpatients With Bipolar Disorder and Comorbid Borderline Personality Features: Promises and Pitfalls
por: Riemann, Georg, et al.
Publicado: (2021)

The Promises and Pitfalls of Retrieval-Extinction Procedures in Preventing Relapse to Drug Seeking
por: Hutton-Bedbrook, Kate, et al.
Publicado: (2013)

Exploring the Role of Artificial Intelligence in Mental Healthcare: Progress, Pitfalls, and Promises
por: Espejo, Gemma, et al.
Publicado: (2023)

Editorial: Neuroimaging Biomarkers in Mood and Anxiety Disorders
por: Lai, Chien-Han, et al.
Publicado: (2021)

Pharmacotherapy for Alcohol Use Disorders: Physicians’ Perceptions and Practices
por: Ponce Martinez, Caridad, et al.
Publicado: (2016)

A Comparison of Cognitive-Behavioral Therapy and Pharmacotherapy vs. Pharmacotherapy Alone in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)—A Randomized Controlled Trial
por: Corbisiero, Salvatore, et al.
Publicado: (2018)

Editorial: The inflammation markers in schizophrenia and bipolar disorder: Do we have promising results?
por: Arslan, Ayla, et al.
Publicado: (2023)

Micronutrients and Diets in the Treatment of Attention-Deficit/Hyperactivity Disorder: Chances and Pitfalls
por: Lange, Klaus W.
Publicado: (2020)

Promises, Pitfalls, and Basic Guidelines for Applying Machine Learning Classifiers to Psychiatric Imaging Data, with Autism as an Example
por: Kassraian-Fard, Pegah, et al.
Publicado: (2016)

Impact of Substance Use Disorder Pharmacotherapy on Executive Function: A Narrative Review
por: Butler, Kevin, et al.
Publicado: (2019)

The Association of P300 Components With Clinical Characteristics and Efficacy of Pharmacotherapy in Alcohol Use Disorder
por: Yuan, Jing, et al.
Publicado: (2022)

Editorial: Efficacy of Psychological and Psychiatric Treatments and Potential Predictors in Social Anxiety Disorder and Obsessive-Compulsive Disorder
por: Pozza, Andrea
Publicado: (2022)

Editorial: Case reports in anxiety and stress
por: Rajkumar, Ravi Philip
Publicado: (2023)

Editorial: Implementation of evidence-based treatments for child anxiety and related disorders across diverse contexts
por: Becker-Haimes, Emily M., et al.
Publicado: (2023)

Disparities in program enrollment and employment outcomes for veterans with psychiatric and co-occurring substance use disorders referred or enrolled for VHA vocational rehabilitation
por: Sprong, Matthew E., et al.
Publicado: (2023)

Pharmacotherapy for anxiety disorders in children and adolescents
por: Kodish, Ian, et al.
Publicado: (2011)

Cross-species anxiety tests in psychiatry: pitfalls and promises
por: Bach, Dominik R.
Publicado: (2021)

Editorial: Traditional Chinese medicine for depression and anxiety
por: Yang, Xinjing, et al.
Publicado: (2023)

The effectiveness of exposure and response prevention combined with pharmacotherapy for obsessive-compulsive disorder: A systematic review and meta-analysis
por: Mao, Lingyun, et al.
Publicado: (2022)

An umbrella review on the use of antipsychotics in anxiety disorders: A registered report protocol
por: Garakani, Amir, et al.
Publicado: (2022)

Editorial: Bioassays for Assessing Traditional Medicines: Promises and Pitfalls
por: Yang, Zhirui, et al.
Publicado: (2022)

Comorbidity of Obsessive-Compulsive Disorder and Schizotypal Personality Disorder: Clinical Response and Treatment Resistance to Pharmacotherapy in a 3-Year Follow-Up Naturalistic Study
por: Perris, Francesco, et al.
Publicado: (2019)

Editorial: Computational accounts of reinforcement learning and decision making in psychiatric disorders
por: Chase, Henry W., et al.
Publicado: (2022)

Editorial: Neuroinflammation, metabolism, and psychiatric disorders
por: Freyberg, Zachary, et al.
Publicado: (2022)

Editorial: Psychiatric Disorder in Veterans
por: Pasinetti, Giulio M., et al.
Publicado: (2021)

Pharmacotherapy of anxiety disorders: a critical review
por: Koen, Nastassja, et al.
Publicado: (2011)

The Use of Cognitive Screening in Pharmacotherapy Trials for Cognitive Impairment Associated With Schizophrenia
por: Cotter, Jack, et al.
Publicado: (2019)

Neuromodulation Treatments of Pathological Anxiety in Anxiety Disorders, Stressor-Related Disorders, and Major Depressive Disorder: A Dimensional Systematic Review and Meta-Analysis
por: Gay, Florian, et al.
Publicado: (2022)

Editorial: Psychoneuroendocrinology of Psychosis Disorders
por: Rutigliano, Grazia, et al.
Publicado: (2020)

Editorial: Cognition in Mood Disorders
por: Oyesanya, Mayowa, et al.
Publicado: (2020)

Editorial: Sleep and Mood Disorders
por: Verkhratsky, Alexei, et al.
Publicado: (2020)

Editorial: Stress and addictive disorders
por: Huang, Andrew Chih Wei, et al.
Publicado: (2023)

Editorial: The heterogeneity of neuropsychiatric disorders
por: Wu, Zhao-Min, et al.
Publicado: (2023)

Editorial: Invasive Treatments for Obsessive Compulsive Disorder
por: Holland, Marshall T., et al.
Publicado: (2021)

Association between temporomandibular disorders and anxiety: A systematic review
por: dos Santos, Erick Alves, et al.
Publicado: (2022)

The Endocannabinoid System and Cannabidiol's Promise for the Treatment of Substance Use Disorder
por: Chye, Yann, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_np0as40qglj5ia18kak89f0cvd